MILESTONES OF AMBICA

Ambica International Corporation, one of the top pharmaceutical companies in the Philippines with a history of excellence and innovation in the industry.

From its headquarters in Merville, Paranaque City, Ambica is dedicated to improving the accessibility and affordability of safe and effective healthcare products for the well-being of every Filipino.

Ambica envisions itself as the leading catalyst for promoting health and wellness in the country, contributing to sustainable development going into the future.

Here are the significant milestones that Ambica has achieved since its inception.

 

Ambica envisions itself as the leading catalyst for promoting health and wellness in the country, contributing to sustainable development going into the future.

Here are the significant milestones that Ambica has achieved since its inception

TIMELINE

1999
June 1
Year 1999

Ambica journey began with Ace Matrix operating from India to export products through Philippine International Trading (PITC) and started with Botika ng Bayan.

2003
June 6
Year 2003

Ambica International Trading Corporation was incorporated as a company.

2005
June 7
Year 2005

Ambica set as the local distributor and partnered with J.B Chemicals & Parmaceuticals Ldt. (Unique Laboratories) and Wockhardt for the promotion of their products in the Philippines.

2007
June 12
Year 2007

Ambica became the first company to launch Recombinant Insulin & Amlodipine Besylate, Simvastatin, Co-Amoxiclav, Ciprofloxacin in the generics market. Ambica launched four divisions for marketing: Cardiovascular, Dermatology.

2010
June 2
Year 2010

Ambica partnered with Pascual (Pharex), New Market Link for the promotion of their products in the Philippine market.

2011
June 9
Year 2011

Ambica partnered with Unilab, Cathay Drug for the promotion of their products in the Philippine market. Ambica partnered with Generika, TGP for the house brand concept.

2012
June 11
Year 2012

Ambica partnered with Pharex for Vitamin E, GXI for Insulin, Unilab for Skeletan Joint Max Project, Ritemed Generics and house branding, and AstraZeneca for Molecular diagnostics.

2013
June 24
Year 2013

Ambica partnered with Multinational Companies for the promotion of their products in the Philippine Market.

2014
June 18
Year 2014

Ambica became the first launch Reteplase in the Philippines. Ambica partnered with MNC Drugstores for the promotion of their products in the Philippine market.

2015
June 4
Year 2015

Ambica was ranked amongst the Top 10 Pharmaceutical companies in the Philippines. Ambica received the Top Distributor Award for two years in a row. Ambica expanded to Vietnam.

2016
June 2
Year 2016

Ambica Filgrastim in Solution for injection was the first to be granted an entry Philippine National Drug Formulary (PNDF).

2019
June 13
Year 2019

Ambica was ranked Top 5 Pharmaceutical company in the Philippines.

2021
June 7
Year 2021

Ambica was ranked Top 4 Pharmaceutical company in the Philippines. Ambica reached the milestone of becoming the 2nd Largest Local Pharmaceutical Company in November 2021. Ambica was recognized by the Intellectual Property Organization of the Philippines as the “Top Trademark Registration and Top Trademark filer from 2017 to 2021”.

2022
June 16
Year 2022

Ambica was officially known as “Ambica House of Brand”. Ambica received a registration certificate from Intellectual Property Organization of the Philippines for the Company’s enhanced vanilla scent and flavor on the tablets of Ketoanalogues + Essential Amino Acids. Join the dynamic team of Ambica and be part of a company with a proud history of achievements and commitment to excellence in the Pharmaceutical industry.